• Search
  • Helpdesk
  • Sales contact

Resources

Explore our latest insights in clinical trials, delve into new trends in eCOA and ePRO trials, understand therapeutic area-specific challenges, discover recent innovations and technologies enhancing user experience and data quality, and much more to empower your studies.

  • Patient voice
  • Therapeutic areas
  • Expert Channel
  • Operational excellence
  • Kayentis solution
  • Kayentis spirit
  • Upcoming Events
Filter:

Patient voice

See all

Ensure successful outcomes with strong patient collaboration at every stage of your clinical trial

Patients, who live with their conditions daily, have invaluable insights that make them essential partners in developing effective treatments and building successful clinical trials. This is particularly the case for...

Empowering healing: The impact of patient partnerships in clinical trials

The landscape of clinical trials has evolved significantly over recent decades, moving from a purely scientific focus to a more...

How to improve the collaboration between expert patients and healthcare companies?

Why and how could the partnerships between expert patients and healthcare companies be improved?In this insightful interview, Françoise Sellin, a...

Bringing the patient’s voice to clinical trials

In this interview, engagement advocate and cystic fibrosis patient Thomas Smith shares his experiences of being the patient voice in...

Therapeutic areas

See all

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

The management of gastrointestinal tract diseases, especially inflammatory bowel disease (IBD), has been transformed over the past few decades. This has been made possible by the approval of new classes...

Turning experience into evidence: PROs in IBD clinical research

Inflammatory Bowel Disease (IBD), including Crohn’s disease or Ulcerative Colitis, presents a complex and highly individualized clinical picture, making it...

If Patients Want A Better Quality Of Life, Why Isn’t That A Focus For Pharma?

A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific...

Immunology Case Study

Immunology studies present specific challenges: their eCOA build can be complex, site staff must play a key role, and study...

Expert channel

See all

Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising

For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating the scientific value of their molecule. One powerful yet underleveraged...

Leveraging the potential of Patient Reported Outcome (PRO) data to accelerate therapeutic innovation market access

Patients Reported Outcome (PRO) data provide information on patient health that is obtained directly from the patient.PRO measures serve to...

If Patients Want A Better Quality Of Life, Why Isn’t That A Focus For Pharma?

A conversation with Frédéric Fiteni, Ph.D., medical oncologist and oncology PRO specialist, University Hospital of Nîmes, and, member of Kayentis Scientific...

Breaking barriers in pediatric clinical trials: perspectives from two expert clinicians

Interview with Begoña Nafria, Head of the Patient Engagement in Research Department at SJD Research Foundation in Spain, and Vivienne...

Operational excellence

See all

BYOD on the rise

Recent and rapid advances in technology have significantly accelerated the digitalization of clinical trials. The Bring Your Own Device (BYOD) approach, which involves using patients’ own smartphones to collect data...

Strategies to promote BYOD adoption by clinical study sites

Bring Your Own Device (BYOD) approaches have been increasingly adopted in recent years, and the multiple advantages they bring to...

Empowering patients through data: a collaborative vision of clinical data management

In the ever-evolving landscape of clinical trials, the importance of patient-centric approaches and effective data management cannot be overstated. This...

Strategies to overcome clinical trials complexities

Clinical research has always been complex, but a significant increase in the level of complexity of clinical trials can have...

Kayentis solution

See all

Biotech and eCOA vendor: A shared mindset

Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they are operating under tremendous pressure due to time and cost...

Kayentis operational excellence

Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its:Customer-centric approachEnd-to-end project...

Why you should implement a BYOD strategy for your eCOA trial

Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial!...

How Kayentis Helps You Manage The Growing Complexities Of eCOA Trials

We all know clinical trials are more and more complex, involving an increasing number of systems, multiple populations, and an...

Kayentis spirit

See all

How Kayentis reduces the CO2 emissions of your eCOA projects with its carbon neutral program

In 2020, we implemented a carbon neutral program for all our clinical trials.Our goal? To reduce project CO2 emissions without impacting cost, quality or timelines. Download the infographic

Kayentis 2024 Gender Equality Index

In accordance with the provisions of the French "Professional Future" law of September 5, 2018, Kayentis has established its Gender...

The client’s voice: why they consistently choose Kayentis

At Kayentis, client satisfaction isn't just a goal—it's our standard. We pride ourselves on delivering services that embody responsiveness, reliability,...

Why you should join Kayentis

At Kayentis, we value each individual and we form a community that goes beyond the sum of individuals. Our company’s...

Events

See all

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

SCDM 2025

Baltimore, Maryland, USA - 27-30 SEPT 2025
Annual Conference 2025 – SCDMLive